ConductScience.org, home

Paper36367181

Anticancer effects and mechanisms of astragaloside‑IV (Review).

Zhou L and 10 others. Oncol Rep, 2023. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Anticancer effects and mechanisms of astragaloside‑IV (Review). Papers, record 36367181. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36367181

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anticancer effects and mechanisms of astragaloside‑IV (Review).
PubMed
Journal
Oncol Rep
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
4.56
iCite
Revised in PubMed
2026-01-27
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhou LLiangxing
2Li MMengpeng
3Chai ZZhengbin
4Zhang JJunli
5Cao KKuan
6Deng LLei
7Liu YYanming
8Jiao CCun
9Zou GMGang-Ming
10Wu JJibiao
11Han FFabin

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Phosphatidylinositol 3-KinasesMajor topic
Proto-Oncogene Proteins c-aktMajor topic
Animals
Apoptosis
Cell Line, Tumor
Cell Proliferation
Glycogen Synthase Kinase 3 beta
NF-kappa B
Toll-Like Receptor 4
TOR Serine-Threonine Kinases
Saponins
Triterpenes

Source PubMed

Download CSV of topics

References85

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131981573Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.Chem Biol Interact2020https://conductscience.org/library/papers/31981573PubMed
228112375Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.Oncol Rep2017https://conductscience.org/library/papers/28112375PubMed
328179291Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma.Anticancer Res2017https://conductscience.org/library/papers/28179291PubMed
431502185Ethnopharmacology, Phytochemistry, Pharmacology, Toxicology and Clinical Applications of Radix Astragali.Chin J Integr Med2021https://conductscience.org/library/papers/31502185PubMed
535164321Advances in Chemical Composition, Extraction Techniques, Analytical Methods, and Biological Activity of Astragali Radix.Molecules2022https://conductscience.org/library/papers/35164321PubMed
630953514CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling.Mol Cancer2019https://conductscience.org/library/papers/30953514PubMed
725407722A review of recent research progress on the astragalus genus.Molecules2014https://conductscience.org/library/papers/25407722PubMed
825895919The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.Cancer Discov2015https://conductscience.org/library/papers/25895919PubMed
914676209Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells.J Biol Chem2004https://conductscience.org/library/papers/14676209PubMed
1025756512PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism.Cancer Biol Ther2015https://conductscience.org/library/papers/25756512PubMed
1128281965Astragaloside IV Enhances Cisplatin Chemosensitivity in Human Colorectal Cancer via Regulating NOTCH3.Oncol Res2016https://conductscience.org/library/papers/28281965PubMed
1235422920Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway.Am J Transl Res2022https://conductscience.org/library/papers/35422920PubMed
1324343578Autophagy regulation by nutrient signaling.Cell Res2014https://conductscience.org/library/papers/24343578PubMed
1419619488Wnt/beta-catenin signaling: components, mechanisms, and diseases.Dev Cell2009https://conductscience.org/library/papers/19619488PubMed
1526621196Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy.Adv Drug Deliv Rev2016https://conductscience.org/library/papers/26621196PubMed
1632256363Uncovering the Anticancer Mechanisms of Chinese Herbal Medicine Formulas: Therapeutic Alternatives for Liver Cancer.Front Pharmacol2020https://conductscience.org/library/papers/32256363PubMed
1731710893Antitumor effects of immunity-enhancing traditional Chinese medicine.Biomed Pharmacother2020https://conductscience.org/library/papers/31710893PubMed
1831719837Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.Chin Med2019https://conductscience.org/library/papers/31719837PubMed
1930536730Astragaloside IV inhibits cell proliferation in vulvar squamous cell carcinoma through the TGF-β/Smad signaling pathway.Dermatol Ther2019https://conductscience.org/library/papers/30536730PubMed
2031762993Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K/AKT/mTOR signaling pathway.Food Sci Nutr2019https://conductscience.org/library/papers/31762993PubMed

See all 85 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
42740837Research Progress of Multicomponent Co-Loaded Nanomedicine Delivery Systems for Tumor Immunotherapy.Int J Nanomedicine2026https://conductscience.org/library/papers/42740837PubMed
42445833
An E3 Aptamer-Modified T Cell-Derived Exosomal Nanoplatform for Codelivery of Astragaloside IV and PESV: Enhancing Prostate Cancer Therapy Through Immune Modulation with Implications for Clinical Translation.
Int J Nanomedicine2026https://conductscience.org/library/papers/42445833PubMed
42429050Protective effects of Astragaloside IV on various liver diseases: From chemistry to herbal medicines (Review).Int J Mol Med2026https://conductscience.org/library/papers/42429050PubMed
41417465Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives.J Med Chem2026https://conductscience.org/library/papers/41417465PubMed
41235672Astragaloside IV promotes the apoptosis of pancreatic cancer cells by activating endoplasmic reticulum stress through the PERK/ATF4/CHOP signaling pathway.Mol Med Rep2026https://conductscience.org/library/papers/41235672PubMed
41235109Mechanistic insights into the antitumor effects of astragaloside IV and astragalus polysaccharide in digestive system cancers.Front Pharmacol2025https://conductscience.org/library/papers/41235109PubMed
40999449Chinese medicine boosts regenerative medicine in stem cell - based therapy.Stem Cell Res Ther2025https://conductscience.org/library/papers/40999449PubMed
40313623NLRP3 inflammasome as a therapeutic target in doxorubicin-induced cardiotoxicity: role of phytochemicals.Front Pharmacol2025https://conductscience.org/library/papers/40313623PubMed
40141225Th1/Th2 Immune Imbalance in the Spleen of Mice Induced by Hypobaric Hypoxia Stimulation and Therapeutic Intervention of Astragaloside IV.Int J Mol Sci2025https://conductscience.org/library/papers/40141225PubMed
40104701Total Astragalus saponins promote ferroptosis in gastric cancer cells by upregulating SIRT3.Transl Cancer Res2025https://conductscience.org/library/papers/40104701PubMed
40055251IGF1R activates FOXP3-β-catenin signaling to promote breast cancer development.Breast Cancer Res Treat2025https://conductscience.org/library/papers/40055251PubMed
39861073Phytochemical and Biological Investigations of Crude Extracts of Astragalus pisidicus.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39861073PubMed
39081698Astragalus membranaceus: A Review of Its Antitumor Effects on Non-Small Cell Lung Cancer.Cancer Manag Res2024https://conductscience.org/library/papers/39081698PubMed
39064966Research Progress on the Anti-Cancer Effects of Astragalus membranaceus Saponins and Their Mechanisms of Action.Molecules2024https://conductscience.org/library/papers/39064966PubMed
38658950Homologous-magnetic dual-targeted metal-organic framework to improve the Anti-hepatocellular carcinoma efficacy of PD-1 inhibitor.J Nanobiotechnology2024https://conductscience.org/library/papers/38658950PubMed
38361933A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer.Front Immunol2024https://conductscience.org/library/papers/38361933PubMed
38318147Modulation of the vitamin D receptor by traditional Chinese medicines and bioactive compounds: potential therapeutic applications in VDR-dependent diseases.Front Pharmacol2024https://conductscience.org/library/papers/38318147PubMed
38305388Cryptolepine Analog Exhibits Antitumor Activity against Ehrlich Ascites Carcinoma Cells in Mice via Targeting Cell Growth, Oxidative Stress, and PTEN/Akt/mTOR Signaling Pathway.Anticancer Agents Med Chem2024https://conductscience.org/library/papers/38305388PubMed
38289380Single-cell RNA sequencing reveals cellular dynamics and therapeutic effects of astragaloside IV in slow transit constipation.Biomol Biomed2024https://conductscience.org/library/papers/38289380PubMed
38193000Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness.Transl Cancer Res2023https://conductscience.org/library/papers/38193000PubMed

Download CSV of cited by

Genes117

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKR1C21646PubTator's text mininghttps://conductscience.org/library/genes/1646NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
APAF1317PubTator's text mininghttps://conductscience.org/library/genes/317NCBI Gene
ARG1383PubTator's text mininghttps://conductscience.org/library/genes/383NCBI Gene
ATG10160673PubTator's text mininghttps://conductscience.org/library/genes/60673NCBI Gene
ATG129140PubTator's text mininghttps://conductscience.org/library/genes/9140NCBI Gene
ATG1422863PubTator's text mininghttps://conductscience.org/library/genes/22863NCBI Gene
ATG16L155054PubTator's text mininghttps://conductscience.org/library/genes/55054NCBI Gene
ATG4D84971PubTator's text mininghttps://conductscience.org/library/genes/84971NCBI Gene
ATG59474PubTator's text mininghttps://conductscience.org/library/genes/9474NCBI Gene
ATG9B285973PubTator's text mininghttps://conductscience.org/library/genes/285973NCBI Gene
BAK1578PubTator's text mininghttps://conductscience.org/library/genes/578NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2A1597PubTator's text mininghttps://conductscience.org/library/genes/597NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
BCL2L1110018PubTator's text mininghttps://conductscience.org/library/genes/10018NCBI Gene
BCL2L2599PubTator's text mininghttps://conductscience.org/library/genes/599NCBI Gene
BECN18678PubTator's text mininghttps://conductscience.org/library/genes/8678NCBI Gene
BIK638PubTator's text mininghttps://conductscience.org/library/genes/638NCBI Gene

See all 117 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36367181

GET https://conductscience.org/api/papers/v1/36367181/references?page=2